Related by context. All words. (Click for frequent words.) 72 Rheumatoid Arthritis RA 69 Chronic Myeloid Leukemia 69 Rheumatoid Arthritis Patients 69 Overactive Bladder 69 Renal Cell Carcinoma 68 Myelodysplastic Syndromes 67 Ulcerative Colitis 67 Bladder Cancer 67 Autoimmune Diseases 66 Breast Cancer Treatment 66 Enlarged Prostate 66 Lupus Nephritis 66 Severe Asthma 66 Autoimmune Disease 66 Ankylosing Spondylitis 66 Diabetic Nephropathy 65 Allergic Rhinitis 65 Inflammatory Bowel Disease 65 Therapeutic Potential 65 Hepatitis C Virus 65 Investigational Treatment 65 Malignant Melanoma 65 Pulmonary Arterial Hypertension 65 Investigational Drug 65 Emerging Therapies 65 Previously Treated 65 Advanced Melanoma 64 Disease Progression 64 Stomach Cancer 64 Gastric Cancer 64 Acute Myeloid Leukemia 64 Pancreatic Cancer 64 Thyroid Cancer 64 Multiple Myeloma Patients 64 Atopic Dermatitis 64 Knee Osteoarthritis 64 Breast Cancer Recurrence 64 rheumatoid arthritis 64 Subgroup Analysis 64 Relapsing Remitting Multiple Sclerosis 64 Benign Prostatic Hyperplasia 64 Psychiatric Disorders 64 Clinical Trial Results 63 Interstitial Cystitis 63 Stem Cell Treatment 63 Insulin Resistance 63 Postmenopausal Women 63 Treating Chronic 63 Relapsed Refractory 63 Antitumor Activity 63 Multiple Sclerosis 63 Neuropathic Pain 63 Chronic Hepatitis C 63 Migraine Headaches 63 Rheumatoid 63 Psoriatic Arthritis 63 Solid Tumors 63 Diabetic Patients 63 Psoriasis Patients 63 Aggressive Prostate Cancer 62 Meets Primary Endpoint 62 Phase III Trial 62 Gout Drug 62 Hepatocellular Carcinoma 62 Investigational Agent 62 Prolongs Survival 62 Crohn Disease 62 Chronic Hepatitis B 62 Liver Cancer 62 Relapsing Multiple Sclerosis 62 Chronic Lymphocytic Leukemia 62 Chronic Sinusitis 62 Cell Lymphoma 62 Resistant Hypertension 62 Improved Survival 62 Chronic Myelogenous Leukemia 62 Patients Suffering 62 Cognitive Impairment 62 Myelofibrosis 62 Metastatic Prostate Cancer 62 Chronic Lymphocytic Leukemia CLL 62 Etanercept 62 Kidney Disease 62 Ischemic Stroke 62 Cutaneous T 62 Breast Cancers 62 Newly Diagnosed Multiple Myeloma 62 Phase IIb Trial 62 Pulmonary Hypertension 62 systemic lupus erythematosus 62 Renal Cancer 62 Drug Candidate 62 Phase III Clinical Trial 62 Survival Benefit 62 Severe Sepsis 62 Autoimmune 62 Oral Fingolimod 62 Friedreich Ataxia 62 Pivotal Trials 62 Combination Treatment 62 Endometrial Cancer 62 Newly Diagnosed 61 Mantle Cell Lymphoma 61 Generalized Anxiety Disorder 61 Advanced Prostate Cancer 61 Acute Heart Failure 61 Growth Hormone Deficiency 61 Advanced Renal Cell 61 Improve Survival 61 Migraine Pain 61 Diabetic Retinopathy 61 Uterine Fibroids 61 Schizophrenia Drug 61 Breast Cancer Metastasis 61 Improves Outcomes 61 Novel Mechanism 61 Combination Therapy 61 Long Term Efficacy 61 Novel Treatments 61 Kidney Function 61 Slow Progression 61 Cardiovascular Outcomes 61 Mouse Model 61 Phase III Trials 61 Multiple Myeloma 61 Golimumab 61 Lung Cancer Drug 61 Phase 2b Clinical Trial 61 Castration Resistant Prostate Cancer 61 Acute Coronary Syndromes 61 Septic Shock 61 Phase IIa Clinical Trial 61 Juvenile Idiopathic Arthritis 61 Dyslipidemia 61 Chronic Constipation 61 Erectile Dysfunction Drug 61 Gastrointestinal Disorders 61 Brain Tumors 61 Acute Ischemic Stroke 61 Lung Cancer Patients 61 rheumatoid arthritis RA 61 Hypercholesterolemia 61 Tiotropium 61 Chronic Heart Failure 61 JAK Inhibitor 61 Placebo Controlled Study 61 Metastatic Colorectal Cancer 61 PsA 61 Preclinical Efficacy 61 Improves Survival 61 Patients Treated With 61 Leukemias 61 Patients Receiving 61 Gene Linked 61 Colorectal Cancer Patients 61 Advanced Colorectal Cancer 61 Dupuytren Contracture 61 Irritable Bowel Syndrome 61 Major Depressive Disorder 61 Diabetic Neuropathy 61 Soft Tissue Sarcoma 61 Treatment Naive 61 Monotherapy 60 Osteoporosis Drug 60 Critical Limb Ischemia 60 Anticancer Activity 60 Blood Pressure Drug 60 Treating Heart Failure 60 HER2 Positive Breast Cancer 60 Glioblastoma Multiforme 60 B Cell Lymphoma 60 Gene Mutation 60 Phase 2a Clinical Trial 60 Irritable Bowel Syndrome IBS 60 Lung Cancer Trial 60 Antipsychotic 60 RNAi Therapeutics 60 Fibromyalgia Syndrome 60 Prostate Cancer Patients 60 Cancer Treatments 60 Phase IIb Clinical Trial 60 Treatment Resistant 60 Autoimmune Disorders 60 Treatment Regimen 60 Paroxysmal Nocturnal Hemoglobinuria PNH 60 Genetic Variations 60 Inflammatory Disease 60 Gaucher Disease 60 Drug Shows Promise 60 juvenile idiopathic arthritis 60 Fabry Disease 60 Short Stature 60 Anti TNF 60 Iron Overload 60 Investigational Compound 60 Receptor Agonist 60 Phase 2b Study 60 Prostate Cancer Treatment 60 Asthma COPD 60 Ischemic 60 Monoclonal Antibody 60 Acute Leukemia 60 Migraine Drug 60 Patients Treated 60 Idiopathic Pulmonary Fibrosis 60 Rheumatoid Arthritis Drug 60 Venous Thromboembolism 60 Chronic Pain 60 Stem Cell Transplants 60 Parkinson Disease PD 60 Liver Failure 60 Systemic Lupus Erythematosus 60 Epilepsy Drug 60 Unresectable 60 Lupus Drug 60 Sustained Efficacy 60 Metabolic Disorder 60 Immune Mediated 60 Phase 2b Trial 60 Therapeutic Targets 60 Novel Oral 60 Complicated Skin 60 Psoriasis 60 Effectively Treats 60 Heart Failure Patients 60 Sleep Disturbances 60 Meta Analysis 60 Gene Variant 60 Sustained Reduction 60 Stem Cell Transplant 60 Tolerability 60 Chronic Pelvic Pain 60 Inflammatory Markers 60 Peripheral Artery Disease 60 Hepatitis C Genotype 60 Psoriasis Drug 60 Cognitive Function 60 Clinical Trial Evaluating 60 Combo Therapy 60 Antiangiogenic 60 Genetic Variation 60 Inflammatory Arthritis 60 Drug Resistant 60 Previously Untreated 60 Age Related Macular 59 Minimally Invasive Treatment 59 Systemic Lupus Erythematosus SLE 59 Esophageal Cancer 59 Bipolar Depression 59 Systemic Juvenile Idiopathic 59 Prostate Cancer Vaccine 59 Inflammatory Diseases 59 Inhaled Corticosteroids 59 Clostridium difficile Infection 59 Pivotal Study 59 Natalizumab 59 Stress Urinary Incontinence 59 Elderly Patients 59 Statistically Significant 59 Early Diagnosis 59 Hepatic Encephalopathy 59 Osteoporotic 59 Tyrosine Kinase Inhibitor 59 Kidney Failure 59 Malignant Glioma 59 Diabetic Foot Ulcers 59 Acute Coronary Syndrome 59 Predict Risk 59 Brain Atrophy 59 Anthracycline 59 Proves Effective 59 Atypical Antipsychotics 59 Viral Infection 59 Shows Promising 59 Breast Cancer Patients 59 Chronic Kidney Disease 59 Anti Tumor 59 Efficacy Trial 59 Polycystic Ovary Syndrome 59 Valvular Heart Disease 59 Novel Therapies 59 Advanced Ovarian Cancer 59 Blood Cancers 59 Demonstrates Efficacy 59 Genetic Variant 59 Demonstrates Potent 59 Bone Marrow Stem Cells 59 Clinical Outcome 59 Improve Outcomes 59 Urinary Incontinence 59 Bortezomib 59 Novel Antibiotic 59 Pharmacological 59 ankylosing spondylitis 59 polyarticular 59 Neovascular Age Related Macular 59 Eculizumab 59 Preclinical Models 59 Gum Disease 59 Data Suggest 59 Osteoarthritis Patients 59 Invasive Breast Cancer 59 Kidney Stones 59 Tumor Growth 59 Relapsed Multiple Myeloma 59 Advanced Pancreatic Cancer 59 Well Tolerated 59 Study Evaluating 59 Liver Disease 59 Secondary Hyperparathyroidism 59 Hemorrhagic Stroke 59 Parkinson Disease 59 Anemia Drug 59 Estrogen Therapy 59 Myeloma Patients 59 Therapeutic Antibody 59 Obesity Linked 59 Cancer Therapies 59 Pediatric Patients 59 Glatiramer Acetate 59 Enzyme Replacement Therapy 59 Parkinson disease PD 59 Fracture Risk 59 Presents Positive 59 Peripheral Arterial Disease 59 Blood Clots 59 Appears Safe 59 Interferon Beta 59 Iron Deficiency 59 Metastatic Cancer 59 Metastatic Melanoma 59 Kidney Transplant Patients 59 ACE Inhibitors 59 Cancer Vaccines 59 Cognitive Deficits 59 Bone Metastases 58 Epidermal Growth Factor Receptor 58 Safinamide 58 Gene Therapy Trial 58 LHON 58 Postmenopausal Osteoporosis 58 Neuroprotective Effects 58 T Cell Lymphoma 58 Myelodysplastic Syndrome 58 Glioma 58 Neurodegenerative 58 Bosentan 58 Shows Efficacy 58 Systemic Sclerosis 58 Treatable 58 Lung Cancer Survival 58 Demonstrates Positive 58 Kinase Inhibitor 58 Osteoarthritis Pain 58 Obese Patients 58 Malaria Vaccine 58 Statin Therapy 58 Treatment Shows Promise 58 Effective Treatments 58 Follicular Lymphoma 58 Renal Anemia 58 Skeletal Muscle 58 Decitabine 58 Cholesterol Levels 58 adalimumab Humira 58 Bosutinib 58 Severe Primary IGFD 58 Anti Angiogenesis 58 Arthritis 58 Autologous Stem Cell Transplantation 58 Osteoporosis Drugs 58 Therapy Evaluation 58 Dose Escalation 58 Ovarian Cancer Patients 58 Genes Linked 58 Pooled Analysis 58 Metastatic Renal Cell Carcinoma 58 Naive Patients 58 Significantly Improved 58 Arthritis Drug 58 Prophylactic Treatment 58 Stakeholder Opinions 58 Initiates Phase III 58 Fibrosis 58 Diabetic Foot Ulcer 58 Lowers Risk 58 Signaling Pathway 58 Partial Onset Seizures 58 Venous Thrombosis 58 Peanut Allergy 58 Preclinical Data 58 Acute Promyelocytic Leukemia 58 Pneumococcal Vaccine 58 Congestive Heart Failure 58 Genetic Mutations 58 Clinical Study 58 Treatment Naive Patients 58 Chronic Inflammatory 58 Uric Acid 58 Tocilizumab 58 Renal Function 58 Adalimumab 58 Novel Therapeutic 58 Monoclonal Antibodies 58 Sleep Duration 58 Restless Legs Syndrome RLS 58 Colorectal Adenomas 58 II Clinical Trial 58 Pivotal Phase III 58 Adjuvant Chemotherapy 58 Systemic Delivery 58 Cardiovascular Events 58 Artery Disease 58 Cholesterol Lowering Drug 58 Pre Eclampsia 58 Dose Escalation Study 58 Bipolar Mania 58 Efficacious 58 Squamous Cell Carcinoma 58 Hepatitis C Infection 58 Ofatumumab 58 B Cell Malignancies 58 Anticancer 58 Treatment Reduces 58 Glucocorticoid 58 Juvenile Rheumatoid Arthritis 58 Orally Active 58 Nonalcoholic Fatty Liver Disease 58 Infected Patients 58 Study Showed 58 Breast Tumors 58 Cluster Headaches 58 Receives Orphan Drug Designation 58 Cimzia ® certolizumab pegol 58 Respiratory Distress 58 Antiplatelet Therapy 58 Genetic Disorder 58 Unfractionated Heparin 58 Immunosuppressant 58 Alemtuzumab 58 Restless Legs Syndrome 58 Acute Renal Failure 58 Adjuvant Treatment 58 Demonstrated Significant 58 Mitral Regurgitation 58 Angioedema 58 Patient Enrollment 58 relapsing multiple sclerosis 58 Beta Blocker 58 Chronic Inflammation 58 FDA Approves Drug 58 Protease Inhibitor 58 Is Well Tolerated 58 Neuroendocrine Tumors 58 Migraine Headache 58 Osteoporosis Treatment 58 rheumatoid arthritis psoriatic arthritis 58 Hepatotoxicity 58 Clinical Efficacy 58 Low Dose 58 Adjuvant Therapy 58 Malignant Brain Tumor 58 Acute Myelogenous Leukemia 58 Aliskiren 57 Controlled Study 57 Panic Disorder 57 Brentuximab Vedotin SGN 57 Postherpetic Neuralgia 57 Menopausal Women 57 Laryngeal Cancer 57 Prospective Randomized 57 Juvenile Arthritis 57 Sleep Disorder 57 Severe Acne 57 Nymox NX 57 Present Preclinical Data 57 Bowel Disease 57 Osteoarthritis 57 fibromyalgia syndrome 57 Chronic Fatigue Syndrome CFS 57 Treated Patients 57 Hematological Cancers 57 Menopausal Symptoms 57 Diuretic 57 Drug Combo 57 Phase 2a Trial 57 Fungal Infections 57 HCV Protease Inhibitor 57 Thyroid Hormone 57 Social Phobia 57 Chemotherapy induced 57 Hypertensive Patients 57 Treatment Options 57 Clinical Trial 57 Allergic Asthma 57 Topical Treatment 57 NDA Submission 57 Neuroprotection 57 Alzheimers Disease 57 Pharmacokinetic Study 57 Cardiovascular Risk 57 Serious Infections 57 Showed Significant 57 Diagnosis Treatment 57 Esophagitis 57 Chronic Fatigue Syndrome 57 Successfully Treated 57 Myocardial Ischemia 57 Cholesterol Drugs 57 Fibromyalgia Pain 57 Romidepsin 57 Cancer Vaccine 57 Reduced Risk 57 Chronic Prostatitis 57 Visceral Fat 57 Crohn disease 57 Hepatitis C Patients 57 Thyroid Disease 57 Pivotal Trial 57 KRN# 57 Bronchiectasis 57 Benign Prostatic Hyperplasia BPH 57 Randomized Controlled Trials 57 Inhaled Liposomal Ciprofloxacin 57 Multicenter Trial 57 Radiofrequency Ablation 57 RhuDex 57 Premature Ejaculation 57 Neural Stem Cells 57 Diagnostic Criteria 57 Pleural Mesothelioma 57 Insulin Sensitivity 57 Anticancer Drugs 57 Hormone Refractory Prostate Cancer 57 Genetic Markers 57 FDA Accepts 57 Anticoagulant 57 Cardiovascular Disease Risk 57 Nerve Pain 57 Cocaine Addiction 57 Bacterial Infections 57 Carcinoid 57 Long Term Survival 57 Synthetic Peptide 57 Small Molecule 57 Pivotal Phase 57 Metastatic Pancreatic Cancer 57 Omacetaxine 57 Ovarian Cancer Treatment 57 Alcohol Consumption 57 Non Hodgkin Lymphoma 57 Antipsychotic Medications 57 Companion Diagnostic 57 Obstructive Sleep Apnoea 57 Vasculitis 57 Pemphigus 57 Metastases 57 Randomized Double blind 57 Myelodysplastic Syndrome MDS 57 Nicotine Addiction 57 Valsartan 57 Therapeutic Efficacy 57 Adjunctive Therapy 57 Disease Modification 57 Atypical Hemolytic Uremic Syndrome 57 Anticancer Agent 57 systemic juvenile idiopathic 57 Thrombotic 57 Recombinant Human 57 Drug Prevents 57 Predict Prostate Cancer 57 Antitumor 57 painful diabetic neuropathy 57 Recurrent Stroke 57 Chemotherapy Regimen 57 Granulocyte Colony Stimulating Factor 57 Progressive Multifocal Leukoencephalopathy 57 Dendritic Cells 57 Anti Clotting Drug 57 Neoplasms 57 Disease Modifying 57 Aurora Kinase 57 AAT Deficiency 57 Ustekinumab 57 Rituximab 57 Sapacitabine 57 Versus Placebo 57 Chronic HCV 57 Plaque Psoriasis 57 Melphalan 57 Lumbar Spine 57 Cholesterol Drug 57 Cancer Stem Cells 57 Rotavirus Vaccine 57 FDA Approvals 57 Gestational Diabetes 57 Postnatal Depression 57 Irritable Bowel 57 Statin Drugs 57 inflammatory arthritis 57 Breast Cancer Risk 57 Therapy Improves 57 Immunosuppression 57 Beneficial Effects 57 Carcinoma 56 Antipsychotic Drug 56 Fx #A 56 Double Blind Placebo 56 Liver Injury 56 Erythropoietic 56 Gastric Bypass Surgery 56 Lung Function 56 Genes Predict 56 Low Testosterone 56 Dasatinib 56 Virus Infection 56 TB Vaccine 56 Breast Cancer Survival 56 Liver Damage 56 Parkinsons Disease 56 Slows Progression 56 Chronic Bronchitis 56 Presents Preclinical Data 56 systemic fungal infections 56 Cardiovascular Mortality 56 Proven Effective 56 Sexual Dysfunction 56 Chronic Renal Failure 56 Cannabinoid 56 Generalized Anxiety Disorder GAD 56 Diabetic Ulcers 56 Chemoradiation 56 Preclinical Study 56 Controlled Trial 56 Meet Primary Endpoint 56 Surgical Treatment 56 RNAi Therapeutic 56 Malignancies 56 Inflammatory Bowel Diseases 56 Non Responders 56 Bevacizumab 56 Schizophrenia Treatment 56 Osteoarthritis Knee Pain 56 Radiofrequency Ablation RFA 56 Denufosol 56 Childhood Leukemia 56 Bladder Control 56 Survival Rates 56 familial amyloidotic polyneuropathy FAP 56 Cell Transplant 56 Potentially Fatal 56 Pelvic Pain 56 Hyperuricemia 56 Thromboembolism 56 secondary hyperparathyroidism 56 Chronic Cough 56 Hematologic 56 Universal Flu Vaccine 56 diabetic nephropathy 56 HER2 Positive 56 Nicotine Vaccine 56 Initiate Clinical Trial 56 Peginterferon Alfa 2b 56 Sclerosis 56 Acute Exacerbations 56 Systolic Hypertension 56 Radical Prostatectomy 56 Eye Diseases 56 Shows Promise Against 56 Antidepressant Use 56 Drug Pipeline 56 Nephrotic Syndrome 56 Carboplatin Paclitaxel 56 Oral Mucositis 56 Relapsed Refractory Multiple Myeloma 56 Diabetes Mellitus 56 Targeted Therapy 56 Lung Injury 56 Lymphoma 56 Antisense Drug 56 Hormone Therapy 56 Patent Covering 56 Hepatocellular Carcinoma HCC 56 Hedgehog Pathway 56 Hospital Acquired Pneumonia 56 Genetic Predisposition 56 Stroke Risk 56 osteoarthritis 56 Asthma Symptoms 56 Epratuzumab 56 Systematic Review 56 Left Ventricular 56 Initiate Phase 56 Cell Lung Cancer 56 Chemotherapeutic Agents 56 Completes Patient Enrollment 56 Preterm Delivery 56 Cancer Recurrence 56 Granted Orphan Drug 56 Acute Myeloid Leukemia AML 56 Trigeminal Neuralgia 56 Lymphoid 56 Metabolic Disease 56 Novel Compound 56 Orphan Status 56 Oral Interferon 56 Cardiotoxicity 56 Bird Flu Vaccine 56 Seasonal Allergic Rhinitis 56 Long Term Outcomes 56 Initiates Clinical Trial 56 Antiviral Activity 56 Premenopausal Women 56 Tolvaptan 56 ISTODAX ® 56 Drug Fails 56 Cardiovascular Risk Factors 56 Skin Cancers 56 Factor Receptor 56 Catena ® 56 Hip Fractures 56 First Patient Dosed 56 Randomized Study 56 RNA Interference 56 Epileptic Seizures 56 Anticancer Drug 56 Neoadjuvant Chemotherapy 56 Breast Cancer Cells 56 debilitating autoimmune 56 Molecular Basis 56 Migraine 56 Corticosteroids 56 TNF Blockers 56 Alzheimer Disease AD 56 Tumor Suppressor 56 Kidney Transplants 56 Anti Inflammatory 56 Cognitive Problems 56 Hereditary Angioedema 56 Mayo Clinic Study Finds 56 Anti Tumor Activity 56 Darbepoetin Alfa 56 Chronic Kidney 56 Experimental Vaccine 56 Lung Cancer Treatment 56 Genetic Testing 56 Post Operative 56 Potent Antiviral Activity 56 Lubiprostone 56 Treatment Approaches 56 Placebo Controlled Trial 56 systemic lupus erythematosus SLE 56 PKC# 56 ST Elevation Myocardial 56 Kepivance 56 Therapeutic Vaccine 56 Renal Cell Cancer 56 Epoetin Alfa 56 Vitamin D Deficiency 56 Adjuvant 56 Blood Thinner 56 Infliximab 56 ARIXTRA R 56 Cell Proliferation 56 Lung Cancer Risk 56 Testicular Cancer 56 biologic therapy 56 Randomized Double Blind Placebo 56 antibody MAb 56 Adenoma 56 Immunotherapeutic 56 Adjunctive 56 Skin Condition 56 Randomized Clinical Trial 56 Orphan Drug 56 Antidepressant Drug 56 Shingles Vaccine 56 Acute Decompensated Heart Failure 56 ankylosing spondylitis AS 56 Liver Cirrhosis 56 Randomized Phase 56 Regenerative Cells 56 Non Inferiority 56 Hepatitis C Treatment 56 Immune Cells 56 Acne Drug 56 Transplant Patients 56 Blinatumomab 56 Cetrorelix 56 Metastatic Breast Cancer 56 Acute Attacks 56 Statin Use 56 Peripheral Neuropathy 56 Cancer Immunotherapy 56 Poorly Controlled 55 Panic Attacks 55 Social Anxiety Disorder 55 Cognitive Decline 55 Surgical Procedures 55 Aortic Stenosis 55 Demonstrates Significant 55 Receives Orphan Drug 55 Pirfenidone 55 Spondylitis 55 Therapeutic Antibodies 55 Pivotal Clinical Trial 55 psoriatic arthritis 55 Brain Scans 55 eosinophilic asthma 55 Suicidality 55 Antiviral Therapy 55 Node Positive 55 Hsp# Inhibitor 55 Phase III Clinical Trials 55 Community Acquired Pneumonia 55 Reflux Disease 55 Predict Response 55 Peginterferon 55 Hospitalized Patients 55 Increased Risk 55 Artificial Pancreas 55 Chronic Migraine 55 Cinacalcet 55 Abatacept 55 NICE Recommends 55 Exercise Induced Asthma 55 Neuropathy 55 Glycemic Control 55 Commercialize Novel 55 Sjogren Syndrome 55 Sipuleucel T 55 Neurological Diseases 55 Hematological Malignancies 55 Bone Fractures 55 rheumatic disease 55 Gene Mutations 55 Dyskinesia 55 Therapeutic Effects 55 Fludarabine 55 Study Demonstrates 55 Bacterial Infection 55 JAK2 Inhibitor 55 Carotid Stenting 55 Subtypes 55 Angiogenic 55 Pegylated Interferon 55 Dupuytren Disease 55 Pregabalin 55 Treat Heart Failure 55 Completes Enrollment 55 Patient Outcomes 55 Diabetic Neuropathic Pain 55 Single Dose 55 Phase 1b Clinical Trial 55 Spinal Fusion 55 Diabetic Macular Edema 55 Huntington Disease 55 atypical Hemolytic Uremic Syndrome 55 First Patient Enrolled 55 psoriasis 55 Cancer Diagnosis 55 Gastrointestinal Stromal Tumors 55 Hip Fracture 55 Antiviral Drugs 55 Muscle Pain 55 HCV Infection 55 Beta Blockers 55 SNT MC# 55 Autoimmunity 55 Targeted Therapies 55 Idiopathic Thrombocytopenic Purpura ITP 55 Systemic lupus erythematosus SLE 55 Antifungals 55 Liver Metastases 55 Ocrelizumab 55 Vitro Activity 55 Viral Suppression 55 Fondaparinux 55 Hemodialysis Patients 55 Zoledronic Acid 55 Acute Myelogenous Leukemia AML 55 Overactive Bladder OAB 55 Adult ADHD 55 Shown Effective 55 Non Hodgkin 55 Platelet Inhibition 55 Bone Marrow Cells 55 Efficacy Results 55 Prolongs Life 55 Female Sexual Arousal 55 Combination REOLYSIN R 55 AA Amyloidosis 55 Nocturia 55 ATTR PN 55 diabetic neuropathic pain 55 Heart Failure 55 Oral Cladribine 55 Replacement Therapy 55 Schizoaffective Disorder 55 Aripiprazole 55 Chronic Myeloid Leukemia CML 55 rheumatoid arthritis Crohn disease 55 Primary Immune Deficiency 55 Study Casts Doubt 55 Orphan Diseases 55 Active Rheumatoid Arthritis 55 Diabetic Kidney Disease 55 Hepatitis B Vaccine 55 Cervical Cancer Vaccine 55 Significantly Reduced 55 Endovascular Treatment 55 Stakeholder Insight 55 Acute Pancreatitis 55 Patients Undergoing 55 Androgen Deprivation Therapy 55 Initiates Clinical 55 HeFH 55 Archexin 55 Asthma Treatment 55 Breast Density 55 Brain Cells 55 FOLOTYN ® 55 Demonstrates Sustained 55 Plus Ribavirin 55 Male Contraceptive 55 Asthma Attacks 55 Intervention Effectiveness 55 Regimens 55 Cell Transplants 55 Li Fraumeni Syndrome 55 Cellular Immunotherapy 55 Immune Responses 55 Cold Sores 55 Avian Flu Vaccine 55 relapsing remitting MS RRMS 55 Reduce Mortality 55 HIV Integrase 55 Cerebrospinal Fluid 55 Renal Impairment 55 Lung Cancers 55 Heel Pain 55 Myasthenia gravis 55 neuropathic pain 55 Drug Resistant TB 55 Respiratory Infections 55 Vitamin D Levels 55 Cyclophosphamide 55 Chronic Insomnia 55 Blood Pressure Lowering 55 Vaccine Candidate 55 Phase IIIb 55 Contrast Agent 55 Non Alcoholic Fatty 55 Pfizer Lyrica 55 STELARA TM 55 Psoriatic arthritis 55 Prognostic Factors 55 Novel Anticancer 55 Smooth Muscle 55 Apaziquone 55 Critical Limb Ischemia CLI 55 Attenuates 55 Coronary Heart Disease 55 Cimzia certolizumab pegol 55 Genital Herpes 55 Nilotinib 55 Lower Urinary Tract 55 Nitazoxanide 55 Lung Tumors 55 Progenitor Cells 55 Rosacea 55 Receptor Antagonists 55 Successfully Completes Phase 55 Hemolysis 55 Blood Vessels 55 Alternative Treatments 55 Oral Cavity 55 Obstructive Sleep Apnea 55 Prostate Biopsy 55 Male Infertility 55 Eosinophilic 55 Multiple sclerosis MS 55 Romiplostim 55 Diffuse Large B 55 Relapsed Refractory Aggressive 55 Receives Positive Opinion 55 Novel Approaches 55 entitled Formulary Advantages 55 Boceprevir 55 Randomized Trials 55 Vulnerable Plaque 55 Mitoxantrone 55 Low Incidence 55 toenail onychomycosis 55 Hematological 55 Immunologic 55 Genetic Mutation 55 CIDP 55 Polycystic Kidney Disease